drugset / Trial / NCT00122824

Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder

NCT00122824 ↗

Phase 3 Completed 480 enrolled Eli Lilly and Company Boehringer Ingelheim · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a clinical trial assessing duloxetine compared with placebo in patients who have generalized anxiety disorder.

Timeline

Start
2004-06
Primary completion
—
Completion
2005-09

Outcome

Met primary endpoint

paper Both groups of duloxetine-treated patients demonstrated significantly greater improvements in anxiety symptom severity compared with placebo-treated patients as measured by HAM-A total score PMID 17607331 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg —
Subject Duloxetine Small molecule 120 mg —